GlassScriptPhysician profile
Prateek Sharma
NPI 1679831820
$10,955.34
in general payments reported to CMS, 2019-2025
22 companies · $1,590 in 2025
The $1,590 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $1,793 · 2021: $1,585 · 2022: $241 · 2023: $3,802 · 2024: $1,332 · 2025: $1,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,730 · Food and Beverage: $2,994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,730.40 |
| Food and Beverage | $2,994.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,967.74 | 2019-2023 | Supera, Diamondback Peripheral, Xact |
| Medtronic, INC. | $2,118.79 | 2023-2024 | Turbohawk, Abre, Nexpowder |
| Penumbra, INC. | $1,165.27 | 2021-2025 | Indigo System |
| Inari Medical, INC. | $1,127.73 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $619.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $476.22 | 2021-2025 | Impella |
| Angiodynamics, INC. | $423.81 | 2024-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Astrazeneca Pharmaceuticals LP | $257.58 | 2019 | |
| Cardiovascular Systems INC. | $144.78 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.22 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $99.00 | 2021 | |
| Amgen INC. | $90.28 | 2022-2023 | Repatha |
| Boston Scientific Corporation | $88.04 | 2024 | Ekosonic |
| Edwards Lifesciences Corporation | $68.07 | 2023-2024 | Pascal |
| Sanofi-Aventis U.S. LLC | $47.55 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $43.32 | 2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.32 | 2023 | Jardiance |
| Medtronic Vascular, INC. | $16.82 | 2020 | |
| W. L. Gore & Associates, INC. | $14.82 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Merck Sharp & Dohme LLC | $13.49 | 2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $12.56 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prateek Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.